| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances In Brief |
1 Institut National de la Santé et de la Recherche Médicale, Paris, France; 2 Centre dEtude du Polymorphisme Humain, Paris, France; 3 Laboratorio di Oncogenesi Molecolare, Istituto Regina Elena, Roma, Italy; and 4 Cancer Research Unit, Childrens Medical Research Institute, Westmead, New South Wales, Australia
| ABSTRACT |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Materials and Methods |
|---|
|
|
|---|
Culture Conditions and Metaphase Preparations.
Most cell lines were grown in either
-MEM (VA13, R9705, U-2 OS, and SAOS-2) or DMEM (293T, NIH3T3, HT1080, HT1080+POT1, JFCF-6/2H+hTERT, BJ, BJ+hTERT, WI38+hTERT, GM847, DU145, U-2 OS, SKBR-3, 293T, and GM16859) supplemented with 10 or 15% fetal bovine serum. LNCaP, the lymphoblastoid cell lines and PHA-stimulated peripheral blood lymphocytes were cultivated in RPMI +10% fetal bovine serum. For CO-FISH and sister chromatid exchange (SCE) analyses, cells were incubated with BrdUrd (30 µM) for either one or two doubling times before 1- to 2-h incubation with colcemid (0.1 µg/ml) followed by hypotonic shock and fixation (methanol/acetic acid). Some cell cultures were treated with mitomycin C (106 M) for 1 h before the addition of BrdUrd (14)
. Metaphase spreads were obtained by dropping suspensions of fixed cells onto clean glass slides. Preparations were used the next day for telomeric FISH.
CO-FISH and SCE Analysis
Slides were treated before hybridization as described by Cornforth and Eberle (15)
. For telomeric FISH and analysis of fluorescent signals, the procedure we described previously was used (12)
. In preparations from cells incubated for two doubling times, the concentration of 4',6-diamidino-2-phenylindole was increased to 4 µg/ml to distinguish light and dark sister chromatids.
| Results and Discussion |
|---|
|
|
|---|
|
|
An alternative interpretation for the occurrence of the double signals in CO-FISH experiments could be the presence of repeat tracts in which the G-rich/C-rich asymmetry of telomeric strands has been disrupted. It is conceivable that the double-stranded extrachromosomal TTAGGG-repeat DNA fragments in ALT cells may be substrates for non-homologous end joining, resulting in telomeric repeat tracts being added to unprotected chromosome extremities. Given that such fragments could be ligated in any orientation, the resulting product would be a patchwork of interspersed G-rich and C-rich sequences, readily detectable by CO-FISH on both sister chromatids of particular chromosome extremities. Although several of the cell lines examined here are of clonal origin (Table 1)
the chromosomes that exhibited telomeric exchanges varied from metaphase to metaphase (not shown). In contrast, CO-FISH double signals were detected at constant interstitial locations in some aberrant chromosomes carried by VA13 cells (Fig. 1C)
, probably the mark of past nonhomologous end-joining events between two chromosome extremities still carrying telomeric repeats.
As a further and more direct test of whether the double signals detected by CO-FISH result from G-rich repeats being present on the same DNA strand at the opposite extremities of the chromosome caused by putative ligation events, or result from telomeric exchanges, we followed the segregation of CO-FISH telomeric signals after a second round of DNA replication, as above (Fig. 2)
. In the case of G-rich tracts being present on the same strand at opposite extremities (and in the absence of SCE), the dark sister chromatid would appear to be labeled on both extremities. In fact, CO-FISH signals on both extremities of dark sister chromatids were extremely rare compared with the number of CO-FISH signals linked to the lighter sister chromatid with no detectable SCE event (Fig. 2)
. Interestingly, we also observed occasional double signals in these experiments, indicating the occurrence of telomeric exchanges after the second round of replication (Fig. 2)
.
|
Because ALT cells bear very long telomeres, we considered the possibility that telomeric exchanges may be triggered by these long structures independently from the ALT process. Telomerase-positive human cell lines with telomeres of about 40 kb not being available to test this hypothesis, we used mouse embryonic fibroblasts (NIH3T3), the telomeres of which, as judged by quantitative FISH, were at least as long as in ALT cells (not shown; 18
). CO-FISH analyses detected double signals at chromosome extremities in a few NIH3T3 metaphases (Table 1)
. We also examined human cells with mean telomere lengths over 10 kb (BJ+hTERT and WI38+hTERT not shown), 15 kb (HT1080+POT1; Ref. 13
), and 20 kb (JFCF/2H+hTERT, not shown). Again, CO-FISH analyses revealed only occasional double signals in these cells (Table 1)
. This very low frequency suggests that although long telomeres may be a substrate for telomeric exchange, additional factors are required to trigger the high rate of exchange seen in ALT cells.
Because the telomeric exchanges may be occurring between sister chromatids in ALT cells, they could be the result of the same type of DNA-damage response that leads to interstitial SCEs. Nevertheless, they are not observed in normal cells or telomerase-positive tumor cell lines with high SCE rates even when these rates have been increased by several fold in response to a short exposure to mitomycin C (Table 1)
. Furthermore, telomeric exchanges were not observed in primary fibroblasts or lymphoblastoid cell lines derived from Bloom syndrome patients, which have SCEs rates 10- or 12-fold higher than normal cells (Table 1)
. Together, these findings suggest that in most cells, telomeres either are not accumulating DNA damage or are prevented from undergoing exchange events, possibly as a consequence of telomere cap function. In ALT cells, on the other hand, the telomeres may be subject to a significant level of DNA damage (or some other alteration that results in "uncapping" and, therefore, in recognition of the telomere end as a site of DNA damage) and consequently have a strong SCE response. It is important to note that the SCE frequency is increased only at the telomeres of ALT cells, but not at interstitial locations (Table 1)
, including sites containing telomeric repeats (not shown). This observation is in agreement with a recent report showing that ALT cells do not have increased levels of homologous recombination within chromosomes (19)
.
One hypothesis to explain the high frequency of telomeric exchanges in ALT cells would be that several components of the mitotic homologous recombination apparatus have been recruited to the telomere for ALT-mediated telomere lengthening. Presumably, one key outcome of this recruitment is that the proteins required for SCE are present at ALT telomeres. If the telomeric exchanges in ALT cells involve sister chromatids, they may be a side effect of a high concentration of SCE proteins at the telomere, rather than being a part of the ALT lengthening. On the other hand, the data do not exclude the possibility that the telomeric exchanges are interchromosomal or involve extrachromosomal TTAGGG-repeat fragments, in which case they may involve additional mechanisms specific to ALT. Additional experiments are needed to explore the relationship between telomere exchange events detected by CO-FISH and the telomere-lengthening mechanisms operating in ALT cells.
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Requests for reprints: J. Arturo Londoño-Vallejo, INSERM U434, 27 rue Juliette Dodu, 75010 Paris. Phone: 33-1-53725122; Fax: 33-1-53725128; E-mail: londono{at}cephb.fr or Roger Reddel, Cancer Research Unit, Childrens Medical Research Institute, Westmead, New South Wales 2145, Australia. Phone: 61-2-96872800, Fax: 61-2-96872120; E-mail: rreddel{at}cmri.usyd.edu.au
5 L. Colgin, P. Bonnefin, R. Reddel, unpublished observations. ![]()
6 S. Bacchetti, unpublished observations. ![]()
Received 12/24/03. Revised 2/ 7/04. Accepted 2/12/04.
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
L. Oganesian and J. Karlseder Telomeric armor: the layers of end protection J. Cell Sci., November 15, 2009; 122(22): 4013 - 4025. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Draskovic, N. Arnoult, V. Steiner, S. Bacchetti, P. Lomonte, and A. Londono-Vallejo Probing PML body function in ALT cells reveals spatiotemporal requirements for telomere recombination PNAS, September 15, 2009; 106(37): 15726 - 15731. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Tsai, H. Qi, C.-P. Lin, R.-K. Lin, J. E. Kerrigan, S. G. Rzuczek, E. J. LaVoie, J. E. Rice, D. S. Pilch, Y. L. Lyu, et al. A G-quadruplex Stabilizer Induces M-phase Cell Cycle Arrest J. Biol. Chem., August 21, 2009; 284(34): 22535 - 22543. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Fan, F. Zhang, B. Barrett, K. Ren, and P. R. Andreassen A role for monoubiquitinated FANCD2 at telomeres in ALT cells Nucleic Acids Res., April 1, 2009; 37(6): 1740 - 1754. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Muntoni, A. A. Neumann, M. Hills, and R. R. Reddel Telomere elongation involves intra-molecular DNA replication in cells utilizing alternative lengthening of telomeres Hum. Mol. Genet., March 15, 2009; 18(6): 1017 - 1027. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nabetani and F. Ishikawa Unusual Telomeric DNAs in Human Telomerase-Negative Immortalized Cells Mol. Cell. Biol., February 1, 2009; 29(3): 703 - 713. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yehezkel, Y. Segev, E. Viegas-Pequignot, K. Skorecki, and S. Selig Hypomethylation of subtelomeric regions in ICF syndrome is associated with abnormally short telomeres and enhanced transcription from telomeric regions Hum. Mol. Genet., September 15, 2008; 17(18): 2776 - 2789. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Phatak, F. Dai, M. Butler, M.P. Nandakumar, P. L. Gutierrez, M. J. Edelman, H. Hendriks, and A. M. Burger KML001 Cytotoxic Activity Is Associated with Its Binding to Telomeric Sequences and Telomere Erosion in Prostate Cancer Cells Clin. Cancer Res., July 15, 2008; 14(14): 4593 - 4602. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Else, T. J. Giordano, and G. D. Hammer Evaluation of Telomere Length Maintenance Mechanisms in Adrenocortical Carcinoma J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1442 - 1449. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Stagno D'Alcontres, A. Mendez-Bermudez, J. L. Foxon, N. J. Royle, and P. Salomoni Lack of TRF2 in ALT cells causes PML-dependent p53 activation and loss of telomeric DNA J. Cell Biol., December 3, 2007; 179(5): 855 - 867. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Johnson, E. J. Gettings, J. Schwalm, J. Pei, J. R. Testa, S. Litwin, M. von Mehren, and D. Broccoli Whole-Genome Profiling in Liposarcomas Reveals Genetic Alterations Common to Specific Telomere Maintenance Mechanisms Cancer Res., October 1, 2007; 67(19): 9221 - 9228. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Multani and S. Chang WRN at telomeres: implications for aging and cancer J. Cell Sci., March 1, 2007; 120(5): 713 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Akiyama, K. Yusa, H. Hashimoto, A. Poonepalli, M. P. Hande, N. Kakazu, J. Takeda, M. Tachibana, and Y. Shinkai Rad54 is dispensable for the ALT pathway Genes Cells, November 1, 2006; 11(11): 1305 - 1315. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Laud, A. S. Multani, S. M. Bailey, L. Wu, J. Ma, C. Kingsley, M. Lebel, S. Pathak, R. A. DePinho, and S. Chang Elevated telomere-telomere recombination in WRN-deficient, telomere dysfunctional cells promotes escape from senescence and engagement of the ALT pathway Genes & Dev., November 1, 2005; 19(21): 2560 - 2570. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Muntoni and R. R. Reddel The first molecular details of ALT in human tumor cells Hum. Mol. Genet., October 15, 2005; 14(suppl_2): R191 - R196. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. de Lange Shelterin: the protein complex that shapes and safeguards human telomeres Genes & Dev., September 15, 2005; 19(18): 2100 - 2110. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, N. Erdmann, R. J. Giannone, J. Wu, M. Gomez, and Y. Liu An increase in telomere sister chromatid exchange in murine embryonic stem cells possessing critically shortened telomeres PNAS, July 19, 2005; 102(29): 10256 - 10260. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Jeyapalan, H. Varley, J. L. Foxon, R. E. Pollock, A. J. Jeffreys, J. D. Henson, R. R. Reddel, and N. J. Royle Activation of the ALT pathway for telomere maintenance can affect other sequences in the human genome Hum. Mol. Genet., July 1, 2005; 14(13): 1785 - 1794. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Marciniak, D. Cavazos, R. Montellano, Q. Chen, L. Guarente, and F. B. Johnson A Novel Telomere Structure in a Human Alternative Lengthening of Telomeres Cell Line Cancer Res., April 1, 2005; 65(7): 2730 - 2737. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Cesare and J. D. Griffith Telomeric DNA in ALT Cells Is Characterized by Free Telomeric Circles and Heterogeneous t-Loops Mol. Cell. Biol., November 15, 2004; 24(22): 9948 - 9957. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Deocaris, S. C. Kaul, K. Taira, and R. Wadhwa Emerging Technologies: Trendy RNA Tools for Aging Research J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2004; 59(8): B771 - B783. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Bailey, M. A. Brenneman, and E. H. Goodwin Frequent recombination in telomeric DNA may extend the proliferative life of telomerase-negative cells Nucleic Acids Res., July 16, 2004; 32(12): 3743 - 3751. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |